Compare KNF & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNF | AMRX |
|---|---|---|
| Founded | 1917 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | N/A | N/A |
| Metric | KNF | AMRX |
|---|---|---|
| Price | $76.29 | $12.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $96.43 | $13.25 |
| AVG Volume (30 Days) | 462.1K | ★ 1.7M |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.61 | 0.02 |
| Revenue | ★ $3,048,164,000.00 | $2,934,959,000.00 |
| Revenue This Year | $8.66 | $9.99 |
| Revenue Next Year | $5.46 | $6.67 |
| P/E Ratio | ★ $29.60 | $758.81 |
| Revenue Growth | 5.52 | ★ 9.50 |
| 52 Week Low | $58.72 | $6.69 |
| 52 Week High | $108.83 | $12.68 |
| Indicator | KNF | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 63.33 |
| Support Level | $73.68 | $12.12 |
| Resistance Level | $79.11 | $12.43 |
| Average True Range (ATR) | 2.03 | 0.31 |
| MACD | 0.22 | -0.03 |
| Stochastic Oscillator | 59.55 | 81.43 |
Knife River Holding Co is an aggregates-led construction materials and contracting services provider. Its segments include Pacific, Northwest, Mountain, North Central, South, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.